Carole is Director of the Centre for Health Technology Evaluation and an Executive Director at NICE. She has a doctorate in Pharmacology and spent eight years in drug discovery at GlaxoSmithKline on the identification and development of novel pharmaceuticals across multiple therapeutic areas. She has undertaken many academic secondments including to The Institute of Molecular Biology in Geneva and the University of California in Irvine, USA. She contributes to international policy forums, including the WHO advisory groups on Priority Medical Devices and Innovative Technologies and is the past President of Health Technology Assessment International (2013-2015). Carole also is a member of the scientific committee of the European Commission Innovative Medicines Initiative.
Carole’s research interests lie in the scientific methodologies of health technology assessment used in the context of health policy decision making.